[ Price : $8.95]
A group of leaders from government, academia, and the pharmaceutical industry call for sweeping federal action to stabilize the U....[ Price : $8.95]
Cogent Biosciences reports positive data from a Phase 3 study of its KIT inhibitor bezuclastinib, saying that the drug combined wi...[ Price : $8.95]
FDA cites Medispray Laboratories, a finished drug product manufacturer based in Ponda, Goa, India, for significant lapses in its q...[ Price : $8.95]
Intellia Therapeutics reports that a patient who experienced liver toxicity after being administered the companys CRISPR-based the...[ Price : $8.95]
FDA approves Janssens Darzalex Faspro (daratumumab and hyaluronidase-fihj) for adults with high-risk smoldering multiple myeloma (...[ Price : $8.95]
Senate Democrats say they are worried that FDA and HHS may rely on partisan junk science during its recently announced review of t...[ Price : $8.95]
FDA publicly releases an 11/4 complete response letter issued to Biohaven on its NDA seeking approval for troriluzole to treat spi...[ Price : $8.95]
FDA extends by three months its review of Rhythm Pharmaceuticals supplemental NDA for Imcivree (setmelanotide) and its use in trea...